Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 1.16% today. In the last week its performance is -1.09%, and 12.44% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 341.79, so today’s gain of 1.16% is a significant step towards its target price. The GAP today is therefore 0.41%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 65521.75, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.30%.
At the current price of 295.05, it has a dividend yield of *TBA, and its target price is 341.79. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 17.23, as well as a forward P/E of 14.19.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.66%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 8.57%.
Performance for the year is 8.07%. Since its IPO date on 9/17/1991, the total performance to date is -3.69%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1151100, while its average volume is 1657.7. Whilst the total gain today was 1.16%, it did have a day high of -8.65%.
Volatility for this week has been at 2.32%, and 2.04% for the month. The 52-week low for Biogen Inc., BIIB has been 32.30%, while the 52-week-high has reached -11.57%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.01, and the P/S is 5.83, along with a P/B of 5.67. Meanwhile it has a p/cash of 17.26.